The role of circulating biomarkers in peripheral arterial disease

G Saenz-Pipaon, E Martinez-Aguilar, J Orbe… - International Journal of …, 2021‏ - mdpi.com
Peripheral arterial disease (PAD) of the lower extremities is a chronic illness predominantly
of atherosclerotic aetiology, associated to traditional cardiovascular (CV) risk factors. It is …

[HTML][HTML] Editor's choice--European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines on the management of asymptomatic lower limb peripheral …

J Nordanstig, CA Behrendt, I Baumgartner… - European Journal of …, 2024‏ - Elsevier
BIOTRONIK's First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter
vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularisation of …

Systematic Review on the Role of IL-6 and IL-1β in Cardiovascular Diseases

N Katkenov, Z Mukhatayev, S Kozhakhmetov… - Journal of …, 2024‏ - mdpi.com
Cardiovascular diseases (CVDs) are a leading cause of global morbidity and mortality,
significantly driven by chronic inflammation. Interleukin-6 (IL-6) and interleukin-1β (IL-1β) …

An evaluation of inflammatory and endothelial dysfunction markers as determinants of peripheral arterial disease in those with diabetes mellitus

S Zaib, S Ahmad, I Khan, YA Bin Jardan… - Scientific Reports, 2024‏ - nature.com
The most serious long-term effects of diabetes is peripheral artery disease (PAD) which
increases the chance of develo** diabetic foot ulcers, gangrene and even lower limb …

[HTML][HTML] Outcomes of lower extremity endovascular revascularization: potential predictors and prevention strategies

F Biscetti, E Nardella, MM Rando, AL Cecchini… - International Journal of …, 2021‏ - mdpi.com
Peripheral artery disease (PAD) is a manifestation of atherosclerosis, which may affect
arteries of the lower extremities. The most dangerous PAD complication is chronic limb …

Distinct features of vascular diseases in COVID-19

A Ceasovschih, V Sorodoc, A Shor… - Journal of …, 2023‏ - Taylor & Francis
Abstract The Coronavirus Disease 2019 (COVID-19) pandemic was declared in early 2020
after several unexplained pneumonia cases were first reported in Wuhan, China, and …

L-carnitine supplementation increases trimethylamine-N-oxide but not markers of atherosclerosis in healthy aged women

JJ Samulak, AK Sawicka, D Hartmane… - Annals of Nutrition and …, 2019‏ - karger.com
Background: L-carnitine can be metabolized to trimethylamine N-oxide (TMAO), a molecule
that promotes atherogenesis through its interaction with macrophages and lipid metabolism …

[HTML][HTML] A systematic review of interleukins as diagnostic and prognostic biomarkers for peripheral artery disease

N Djahanpour, N Ahsan, B Li, H Khan, K Connelly… - Biomolecules, 2023‏ - mdpi.com
Background: Peripheral artery disease (PAD) involves atherosclerosis of the lower extremity
arteries and is a major contributor to limb loss and death worldwide. Several studies have …

Platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte ratio and monocyte-to-HDL cholesterol ratio as markers of peripheral artery disease in elderly patients

S Selvaggio, A Abate, G Brugaletta… - International …, 2020‏ - spandidos-publications.com
Solid evidence underlines the pivotal role played by inflammation regarding atherosclerosis.
Peripheral artery disease (PAD) is one of atherosclerotic cardiovascular diseases (CVDs), it …

MicroRNA-29a-3p reduces TNFα-induced endothelial dysfunction by targeting tumor necrosis factor receptor 1

X Deng, X Chu, P Wang, X Ma, C Wei, C Sun… - … Therapy Nucleic Acids, 2019‏ - cell.com
miR-29a-3p has been shown to be associated with cardiovascular diseases; however, the
effect of miR-29a-3p on endothelial dysfunction is unclear. This study aimed to reveal the …